Cargando…

(18)F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy

BACKGROUND: Quantitative image analysis based on radiomic feature extraction is an emerging field for survival prediction in oncological patients. (18)F-Fluorethyltyrosine positron emission tomography ((18)F-FET PET) provides important diagnostic and grading information for brain tumors, but data on...

Descripción completa

Detalles Bibliográficos
Autores principales: Wiltgen, Tun, Fleischmann, Daniel F., Kaiser, Lena, Holzgreve, Adrien, Corradini, Stefanie, Landry, Guillaume, Ingrisch, Michael, Popp, Ilinca, Grosu, Anca L., Unterrainer, Marcus, Bartenstein, Peter, Parodi, Katia, Belka, Claus, Albert, Nathalie, Niyazi, Maximilian, Riboldi, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719240/
https://www.ncbi.nlm.nih.gov/pubmed/36461120
http://dx.doi.org/10.1186/s13014-022-02164-6
_version_ 1784843277339459584
author Wiltgen, Tun
Fleischmann, Daniel F.
Kaiser, Lena
Holzgreve, Adrien
Corradini, Stefanie
Landry, Guillaume
Ingrisch, Michael
Popp, Ilinca
Grosu, Anca L.
Unterrainer, Marcus
Bartenstein, Peter
Parodi, Katia
Belka, Claus
Albert, Nathalie
Niyazi, Maximilian
Riboldi, Marco
author_facet Wiltgen, Tun
Fleischmann, Daniel F.
Kaiser, Lena
Holzgreve, Adrien
Corradini, Stefanie
Landry, Guillaume
Ingrisch, Michael
Popp, Ilinca
Grosu, Anca L.
Unterrainer, Marcus
Bartenstein, Peter
Parodi, Katia
Belka, Claus
Albert, Nathalie
Niyazi, Maximilian
Riboldi, Marco
author_sort Wiltgen, Tun
collection PubMed
description BACKGROUND: Quantitative image analysis based on radiomic feature extraction is an emerging field for survival prediction in oncological patients. (18)F-Fluorethyltyrosine positron emission tomography ((18)F-FET PET) provides important diagnostic and grading information for brain tumors, but data on its use in survival prediction is scarce. In this study, we aim at investigating survival prediction based on multiple radiomic features in glioblastoma patients undergoing radio(chemo)therapy. METHODS: A dataset of 37 patients with glioblastoma (WHO grade 4) receiving radio(chemo)therapy was analyzed. Radiomic features were extracted from pre-treatment (18)F-FET PET images, following intensity rebinning with a fixed bin width. Principal component analysis (PCA) was applied for variable selection, aiming at the identification of the most relevant features in survival prediction. Random forest classification and prediction algorithms were optimized on an initial set of 25 patients. Testing of the implemented algorithms was carried out in different scenarios, which included additional 12 patients whose images were acquired with a different scanner to check the reproducibility in prediction results. RESULTS: First order intensity variations and shape features were predominant in the selection of most important radiomic signatures for survival prediction in the available dataset. The major axis length of the (18)F-FET-PET volume at tumor to background ratio (TBR) 1.4 and 1.6 correlated significantly with reduced probability of survival. Additional radiomic features were identified as potential survival predictors in the PTV region, showing 76% accuracy in independent testing for both classification and regression. CONCLUSIONS: (18)F-FET PET prior to radiation provides relevant information for survival prediction in glioblastoma patients. Based on our preliminary analysis, radiomic features in the PTV can be considered a robust dataset for survival prediction.
format Online
Article
Text
id pubmed-9719240
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97192402022-12-04 (18)F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy Wiltgen, Tun Fleischmann, Daniel F. Kaiser, Lena Holzgreve, Adrien Corradini, Stefanie Landry, Guillaume Ingrisch, Michael Popp, Ilinca Grosu, Anca L. Unterrainer, Marcus Bartenstein, Peter Parodi, Katia Belka, Claus Albert, Nathalie Niyazi, Maximilian Riboldi, Marco Radiat Oncol Research BACKGROUND: Quantitative image analysis based on radiomic feature extraction is an emerging field for survival prediction in oncological patients. (18)F-Fluorethyltyrosine positron emission tomography ((18)F-FET PET) provides important diagnostic and grading information for brain tumors, but data on its use in survival prediction is scarce. In this study, we aim at investigating survival prediction based on multiple radiomic features in glioblastoma patients undergoing radio(chemo)therapy. METHODS: A dataset of 37 patients with glioblastoma (WHO grade 4) receiving radio(chemo)therapy was analyzed. Radiomic features were extracted from pre-treatment (18)F-FET PET images, following intensity rebinning with a fixed bin width. Principal component analysis (PCA) was applied for variable selection, aiming at the identification of the most relevant features in survival prediction. Random forest classification and prediction algorithms were optimized on an initial set of 25 patients. Testing of the implemented algorithms was carried out in different scenarios, which included additional 12 patients whose images were acquired with a different scanner to check the reproducibility in prediction results. RESULTS: First order intensity variations and shape features were predominant in the selection of most important radiomic signatures for survival prediction in the available dataset. The major axis length of the (18)F-FET-PET volume at tumor to background ratio (TBR) 1.4 and 1.6 correlated significantly with reduced probability of survival. Additional radiomic features were identified as potential survival predictors in the PTV region, showing 76% accuracy in independent testing for both classification and regression. CONCLUSIONS: (18)F-FET PET prior to radiation provides relevant information for survival prediction in glioblastoma patients. Based on our preliminary analysis, radiomic features in the PTV can be considered a robust dataset for survival prediction. BioMed Central 2022-12-02 /pmc/articles/PMC9719240/ /pubmed/36461120 http://dx.doi.org/10.1186/s13014-022-02164-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wiltgen, Tun
Fleischmann, Daniel F.
Kaiser, Lena
Holzgreve, Adrien
Corradini, Stefanie
Landry, Guillaume
Ingrisch, Michael
Popp, Ilinca
Grosu, Anca L.
Unterrainer, Marcus
Bartenstein, Peter
Parodi, Katia
Belka, Claus
Albert, Nathalie
Niyazi, Maximilian
Riboldi, Marco
(18)F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy
title (18)F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy
title_full (18)F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy
title_fullStr (18)F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy
title_full_unstemmed (18)F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy
title_short (18)F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy
title_sort (18)f-fet pet radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719240/
https://www.ncbi.nlm.nih.gov/pubmed/36461120
http://dx.doi.org/10.1186/s13014-022-02164-6
work_keys_str_mv AT wiltgentun 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy
AT fleischmanndanielf 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy
AT kaiserlena 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy
AT holzgreveadrien 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy
AT corradinistefanie 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy
AT landryguillaume 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy
AT ingrischmichael 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy
AT poppilinca 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy
AT grosuancal 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy
AT unterrainermarcus 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy
AT bartensteinpeter 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy
AT parodikatia 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy
AT belkaclaus 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy
AT albertnathalie 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy
AT niyazimaximilian 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy
AT riboldimarco 18ffetpetradiomicsbasedsurvivalpredictioninglioblastomapatientsreceivingradiochemotherapy